Fasidotril inhibits NEP, which reduces the degradation of ANP and BNP, enhancing their natriuretic and vasodilatory actions, thereby helping to alleviate the symptoms of heart failure (Pathadka et al., 2021). The gene discussed is NPPA; the disease is heart failure.